Create account

Coverage dated October 10, 2021 to October 11, 2021

Merck asks FDA to authorize promising anti-COVID pill

Headline from CBS 8 San Diego, from the development of Oct 11, 2021

Newest development Oct 12, 2021 · 2 reportsMerck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies

The decision on the drug could come in a matter of weeks.

CBS 8 San Diego's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Names this update

    Merck asks FDA to authorize promising anti-COVID pill

    Headline from CBS 8 San Diego ·

  2. Newest

    Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies

    Headline from Forbes ·

Read the reports

Reports & sources

150 articles, oldest first.

  1. WCNC

    Merck asks US FDA to authorize promising anti-COVID pill (opens WCNC)

    Published

    WCNC's feed description

    The company reported earlier this month that the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19.

  2. Los Angeles Times

    Merck asks the FDA to authorize use of its promising COVID-19 pill (opens Los Angeles Times)

    Published

    Los Angeles Times's feed description

    Drugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks.

  3. FOX 6 Milwaukee

    Merck seeks FDA authorization of antiviral COVID-19 pill (opens FOX 6 Milwaukee)

    Published

    FOX 6 Milwaukee's feed description

    Merck asked the FDA to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon against the pandemic.

  4. PBS NewsHour

    Merck asks FDA to authorize anti-COVID pill (opens PBS NewsHour)

    Published

    PBS NewsHour's feed description

    If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat COVID-19.

  5. CBS 8 San Diego

    Merck asks FDA to authorize promising anti-COVID pill (opens CBS 8 San Diego)

    Published

    CBS 8 San Diego's feed description

    The decision on the drug could come in a matter of weeks.

  6. WISH-TV Indianapolis

    Merck asks US FDA to authorize promising anti-COVID pill - WISH-TV | Indianapolis News | Indiana Weather (opens WISH-TV Indianapolis)

    Published

    WISH-TV Indianapolis's feed description

    WASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to […]

  7. Newsweek

    Merck COVID pill vs. ivermectin: What to know about approval, effectiveness, usage (opens Newsweek)

    Published

    Newsweek's feed description

    Merck's oral antiviral could become the first FDA-authorized outpatient therapeutic that doesn't require a health care professional to administer.

  8. New Hampshire Union Leader

    Merck seeks first U.S. authorization for COVID-19 pill (opens New Hampshire Union Leader)

    Published

    New Hampshire Union Leader's feed description

    Merck & Co Inc. said on Monday it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to become

  9. Al Jazeera

    Merck seeks US authorisation for pill to treat COVID (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases.

  10. Boston

    Merck asks U.S. FDA to authorize promising anti-COVID pill (opens Boston)

    Published

    Boston's feed description

    Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19.

  11. Forbes

    Merck Seeks U.S. Emergency Approval For Antiviral Covid Pill (opens Forbes)

    Published

    Forbes's feed description

    A late-stage trial showed the pill, which Merck is developing with Miami-based Ridgeback Therapeutics, halves the chances of hospitalization or death in recently diagnosed patients at risk of severe illness.

  12. Insider

    Top Stories this PM: Merck requests authorization for anti-COVID pill; Facebook Oversight Board to meet with whistleblower (opens Insider)

    Published

    Insider's feed description

    If authorized, the drug, called molnupiravir, would become the first oral antiviral treatment for COVID-19.

  13. France 24

    Merck seeks FDA authorization for Covid treatment pill (opens France 24)

    Published

    France 24's feed description

    Merck seeks FDA authorization for Covid treatment pill

  14. Portland Press Herald

    Drugmaker Merck asks FDA to authorize promising anti-COVID pill (opens Portland Press Herald)

    Published

    Portland Press Herald's feed description

    If approved, it would be the first pill shown to treat the illness.

  15. Insider

    Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out (opens Insider)

    Published

    Insider's feed description

    The pill "significantly reduced the risk of hospitalization or death," according to the developers Merck and Ridgeback Biotherapeutics.

  16. CBS News

    Merck asks FDA for emergency authorization for first pill to treat COVID-19 (opens CBS News)

    Published

    CBS News's feed description

    The giant drugmaker is seeking the emergency authorization for molnupiravir, which it says cut hospitalizations and deaths by half among patients with early COVID-19 symptoms.

  17. Slate Magazine

    Merck Seeks FDA Approval for First Antiviral COVID Pill (opens Slate Magazine)

    Published

    Slate Magazine's feed description

    The drug, molnupiravir, cut hospitalization and death by half among people with a least one risk factor for severe disease.

  18. KVOA Tucson

    Drug company asks for FDA approval of pill to treat COVID-19 (opens KVOA Tucson)

    Published

    KVOA Tucson's feed description

    The company Merck says it has asked the Food and Drug Administration to authorize emergency use of its experimental anti-viral pill to treat COVID-19 in adults.

  19. The Hill

    Merck requests FDA authorization for COVID-19 antiviral pill (opens The Hill)

    Published

    The Hill's feed description

    Merck said on Monday that it has requested authorization from the Food and Drug Administration (FDA) for its antiviral COVID-19 pill.

  20. France 24

    Merck seeks US authorization for Covid treatment pill (opens France 24)

    Published

    France 24's feed description

    Merck seeks US authorization for Covid treatment pill

  21. NBC10 Philadelphia

    Merck Asks FDA to Authorize Antiviral Covid Pill for Emergency Use (opens NBC10 Philadelphia)

    Published

    NBC10 Philadelphia's feed description

    The Covid-19 treatment – known as molnupiravir – could be available to Americans by late this year.

  22. Sioux City Journal

    Merck asks US regulators to authorize promising pill against COVID-19, with decision expected within weeks (opens Sioux City Journal)

    Published

    Sioux City Journal's feed description

    WASHINGTON (AP) — Merck asks US regulators to authorize promising pill against COVID-19, with decision expected within weeks.

  23. NBC News

    Merck asks FDA for emergency authorization for experimental Covid pill (opens NBC News)

    Published

    NBC News's feed description

    If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat Covid-19.

  24. FOX Business

    Merck asks FDA to authorize anti-COVID pill for emergency use (opens FOX Business)

    Published

    FOX Business's feed description

    Drugmaker Merck asked federal health officials Monday to greenlight its experimental pill against COVID-19, which could make history as the first oral antiviral medicine to treat the harrowing virus.

  25. KTVZ Bend

    Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir (opens KTVZ Bend)

    Published

    KTVZ Bend's feed description

    CNN By Jamie Gumbrecht and Maggie Fox, CNN Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the fir…

Showing the first 25 of 32 headlines. ·

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Merck asks FDA to authorize promising anti-COVID pill | Since Then